Fig. 1 | Nature Communications

Fig. 1

From: Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis

Fig. 1

Screening results and prioritization considerations. Confirmed anticryptosporidial screening hits, lowest EC50, and prioritization considerations for four benzoxaborole chemical scaffolds are shown. The 6-carboxamide antitrypanosomal chemical scaffold was prioritized for further study based on a large number of available analogs, existing safety data from a human African trypanosomiasis (HAT) drug development program, and the results of a preliminary murine efficacy study

Back to article page